AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1522190 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular progesterone 12.5 mg q.d. starting from the day after the HCG trigger, increased to 25 mg q.d. on the day of embryo transfer
Number of subjects: 121
Study 6347232 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (0.3-1.2 g single dose)
Number of subjects: 6
Study 6347232 — intervention group
Group type: EXPERIMENTAL
Intervention: Other nonsteroidal anti-inflammatory drugs (oral challenge)
Number of subjects: 6
Study 31274814 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional Care Model (TCM)
Number of subjects: 3000
Study 31274814 — intervention group
Group type: COMPARATOR
Intervention: Current CMS penalties
Number of subjects: 3000
Study 27807213 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticoid therapy
Number of subjects: 119
Study 27807213 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus monotherapy
Number of subjects: 119
Study 25867415 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine A (CsA) alone
Number of subjects: 27
Study 25867415 — intervention group
Group type: COMPARATOR
Intervention: Combination of low-dose hormone and low-dose CsA
Number of subjects: 27
Study 23965841 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy deficit (ED)
Number of subjects: 39
Study 23965841 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-meal consumption
Number of subjects: 39
Study 23965841 — intervention group
Group type: COMPARATOR
Intervention: Weight maintenance (WM)
Number of subjects: 39
Study 23965841 — intervention group
Group type: COMPARATOR
Intervention: Fasted state
Number of subjects: 39
Study 21420129 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic therapy
Number of subjects: 761
Study 21420129 — intervention group
Group type: COMPARATOR
Intervention: Conventional glycemic therapy
Number of subjects: 761
Study 20214212 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy with pelvic autonomic nerve preservation
Number of subjects: 24
Study 20214212 — intervention group
Group type: COMPARATOR
Intervention: Control group without radiation
Number of subjects: 24
Study 20214212 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy
Number of subjects: 24
Study 17146364 — intervention group
Group type: EXPERIMENTAL
Intervention: Drains (20 patients, 20 hips)
Number of subjects: 40
Study 17146364 — intervention group
Group type: COMPARATOR
Intervention: No drains (20 patients, 20 hips)
Number of subjects: 40
Study 14966097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg i.v. before chemotherapy plus 4 mg orally every 6 hours for four doses (arm A)
Number of subjects: 587
Study 14966097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 24 mg i.v. single dose before chemotherapy (arm B)
Number of subjects: 587
Study 14966097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg i.v. single dose before chemotherapy (arm C)
Number of subjects: 587
Study 11337977 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) 3.9 g daily for 63 days
Number of subjects: 17
Study 11337977 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (control group)
Number of subjects: 17
Study 1544953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheffield splint (cast immobilisation for three weeks followed by controlled early mobilisation)
Number of subjects: 40
Study 1544953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheffield splint
Number of subjects: 40
Study 1544953 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast (cast immobilisation for eight weeks)
Number of subjects: 40
Study 1544953 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast
Number of subjects: 40
Study 3922535 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucotriene D4
Number of subjects: 17
Study 3922535 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine
Number of subjects: 17
Study 3922535 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 17
Study 29544472 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (TXA) - 2 g 2 hours before incision, 1 g at 6 and 12 hours after surgery
Number of subjects: 147
Study 29544472 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular tranexamic acid (TXA) - 3 g in 100 mL of saline solution
Number of subjects: 147
Study 29544472 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (TXA)
Number of subjects: 147
Study 29544472 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular tranexamic acid (TXA)
Number of subjects: 147
Study 27265814 — intervention group
Group type: EXPERIMENTAL
Intervention: Early palliative care (EPC) intervention
Number of subjects: 123
Study 27265814 — intervention group
Group type: COMPARATOR
Intervention: Delayed palliative care (EPC) intervention
Number of subjects: 123
Study 24793963 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis BB‐12)
Number of subjects: 192
Study 24793963 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo tablet)
Number of subjects: 192
Study 24793963 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group
Number of subjects: 192
Study 22628382 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with greater domestic violence myths
Number of subjects: 194
Study 22628382 — intervention group
Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 194
Study 22628382 — intervention group
Group type: EXPERIMENTAL
Intervention: Victim who returned to her abuser
Number of subjects: 194
Study 20113305 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT)
Number of subjects: 73
Study 20113305 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual plus waiting list for DBT (TAU+WL)
Number of subjects: 73
Study 17888516 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-phase divalproex
Number of subjects: 0
Study 17888516 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-phase lithium
Number of subjects: 0
Study 17888516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17888516 — intervention group
Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 0
Study 15841383 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone bruise with intra-articular pathology
Number of subjects: 664
Study 15841383 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone bruise without intra-articular pathology
Number of subjects: 664
Study 15841383 — intervention group
Group type: COMPARATOR
Intervention: No bone bruise with intra-articular pathology
Number of subjects: 664
Study 15841383 — intervention group
Group type: COMPARATOR
Intervention: No bone bruise without intra-articular pathology
Number of subjects: 664
Study 12847484 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to kitchen Bla g 1 levels greater than 1 U/g
Number of subjects: 339
Study 11016468 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI plus systemic fluorouracil/folinic acid
Number of subjects: 84
Study 11016468 — intervention group
Group type: COMPARATOR
Intervention: Systemic fluorouracil/folinic acid
Number of subjects: 84
Study 9001834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg administered at bedtime
Number of subjects: 0
Study 9001834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1516762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified diet education and continuous encouragement to increase physical activity
Number of subjects: 78
Study 1516762 — intervention group
Group type: COMPARATOR
Intervention: Conventionally treated group
Number of subjects: 78
Study 1516762 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 78
Study 2870754 — intervention group
Group type: EXPERIMENTAL
Intervention: Active trial or standard medication
Number of subjects: 253
Study 2870754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study 31487415 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Possible Self (BPS) intervention
Number of subjects: 0
Study 29637824 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally applied electroceutical (EAE) device, Accel-Heal, applied for 12 consecutive days.
Number of subjects: 0
Study 29637824 — intervention group
Group type: COMPARATOR
Intervention: Placebo device, identical in appearance to the EAE device, applied for 12 consecutive days.
Number of subjects: 0
Study 29637824 — intervention group
Group type: EXPERIMENTAL
Intervention: EAE device
Number of subjects: 0
Study 29637824 — intervention group
Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 0
Study 26856220 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive hydration with normal saline guided by left ventricular end-diastolic pressure (LVEDP)
Number of subjects: 560
Study 26856220 — intervention group
Group type: COMPARATOR
Intervention: General hydration (control group) with <500 mL normal saline at a normal rate (0.5 or 1 mL/kg.h)
Number of subjects: 560
Study 24795094 — intervention group
Group type: EXPERIMENTAL
Intervention: RHANI Wives intervention
Number of subjects: 220
Study 24795094 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study 22873210 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive neurostimulation (INS) therapy
Number of subjects: 23
Study 22873210 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 23
Study 22197956 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency force steadiness practice in plantar flexor muscles (5 sets of 60-s contraction at 10% and 20% MVC, once or twice a week for 4 weeks)
Number of subjects: 21
Study 22197956 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group (n=7)
Number of subjects: 21
Study 19231198 — intervention group
Group type: EXPERIMENTAL
Intervention: N‐butyl octyl cyanoacrylate (NCA) tissue adhesive
Number of subjects: 40
Study 19231198 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods (nylon monofilament, traditional skin sutures, or metal skin clips)
Number of subjects: 40
Study 19231198 — intervention group
Group type: COMPARATOR
Intervention: Skin clips subgroup
Number of subjects: 40
Study 16809568 — intervention group
Group type: EXPERIMENTAL
Intervention: ADMA (0.10 mg ADMA/kg per min)
Number of subjects: 20
Study 16809568 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 20
Study 12780424 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice plus iron supplement (60 mg Fe2+ - Ferromax)
Number of subjects: 326
Study 12780424 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice plus iron supplement (3.6 mg heme iron plus 24 mg Fe2+ - Hemofer)
Number of subjects: 326
Study 12780424 — intervention group
Group type: COMPARATOR
Intervention: Advice only (Group I)
Number of subjects: 326
Study 11124651 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 microg fenoterol via RMT
Number of subjects: 62
Study 11124651 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 microg fenoterol via RMT
Number of subjects: 62
Study 11124651 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg fenoterol via RMT
Number of subjects: 62
Study 11124651 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg fenoterol via RMT
Number of subjects: 62
Study 11124651 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg fenoterol via RMT
Number of subjects: 62
Study 11124651 — intervention group
Group type: COMPARATOR
Intervention: 100 microg fenoterol via MDI
Number of subjects: 62
Study 11124651 — intervention group
Group type: COMPARATOR
Intervention: 200 microg fenoterol via MDI
Number of subjects: 62
Study 11124651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 9360504 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol (E2; 2 mg, orally) continuously combined with dydrogesterone (2.5 mg)
Number of subjects: 137
Study 9360504 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol (E2; 2 mg, orally) continuously combined with dydrogesterone (5 mg)
Number of subjects: 137
Study 9360504 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol (E2; 2 mg, orally) continuously combined with dydrogesterone (10 mg)
Number of subjects: 137
Study 9360504 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol (E2; 2 mg, orally) continuously combined with dydrogesterone (15 mg)
Number of subjects: 137
Study 1548889 — intervention group
Group type: EXPERIMENTAL
Intervention: Hickman catheters
Number of subjects: 141
Study 1548889 — intervention group
Group type: COMPARATOR
Intervention: Implanted port catheters
Number of subjects: 141
Study 3900846 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (5 mg/dL)
Number of subjects: 545
Study 3900846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 545
Study 31720905 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-nucleotide polymorphism-based analysis (SBA) method using low-coverage whole-genome sequencing (LC-WGS)
Number of subjects: 213
Study 31720905 — intervention group
Group type: COMPARATOR
Intervention: Mass spectrometry verification of negative samples
Number of subjects: 213
Study 30025152 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 minutes) with real ABM
Number of subjects: 98
Study 30025152 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (30 seconds) with control ABM
Number of subjects: 98
Study 30025152 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS with control ABM
Number of subjects: 98
Study 30025152 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS with real ABM
Number of subjects: 98
Study 27177838 — intervention group
Group type: EXPERIMENTAL
Intervention: Central Sleep Apnea (CSA)
Number of subjects: 132
Study 27177838 — intervention group
Group type: COMPARATOR
Intervention: Obstructive Sleep Apnea (OSA)
Number of subjects: 132
Study 24694337 — intervention group
Group type: EXPERIMENTAL
Intervention: 17β‐estradiol (0.1 mg/d via continuous delivery skin patch)
Number of subjects: 27
Study 24694337 — intervention group
Group type: COMPARATOR
Intervention: Progesterone (100 mg/d via vaginal insert)
Number of subjects: 27
Study 24694337 — intervention group
Group type: COMPARATOR
Intervention: Testosterone (12.5 mg/d via skin gel)
Number of subjects: 27
Study 24694337 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study 22319034 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP infusion
Number of subjects: 10
Study 22319034 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 10
Study 22319034 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study 22319034 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie diet and sedentary lifestyle with prednisolone (37.5 mg once daily)
Number of subjects: 10
Study 20926001 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ionized solution (IS)
Number of subjects: 529
Study 20926001 — intervention group
Group type: COMPARATOR
Intervention: Topical saline solution (placebo)
Number of subjects: 529
Study 18618034 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% carbamide peroxide gel
Number of subjects: 30
Study 18618034 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide gel
Number of subjects: 30
Study 18618034 — intervention group
Group type: COMPARATOR
Intervention: 0% carbamide peroxide gel (control group)
Number of subjects: 30
Study 18618034 — intervention group
Group type: EXPERIMENTAL
Intervention: All test groups (17% and 10% carbamide peroxide)
Number of subjects: 30
Study 16418559 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal meridian massage for 5 minutes per day during 6 days from the fifth day before menstruation to the first day of menstruation
Number of subjects: 85
Study 16418559 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 85
Study 12037720 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (retinol) at a dose of 50,000 IU/d for 10 days
Number of subjects: 0
Study 12037720 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) for 10 days
Number of subjects: 0
Study 12037720 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg T(3) after 10 days of PL treatment
Number of subjects: 0
Study 12037720 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg T(3) after 10 days of vitamin A treatment
Number of subjects: 0
Study 12037720 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) for 10 days in elderly subjects
Number of subjects: 0
Study 12037720 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A for 10 days in elderly subjects
Number of subjects: 0
Study 10404854 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol 200 mg once daily
Number of subjects: 40
Study 10404854 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg once daily
Number of subjects: 40
Study 7672750 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 27
Study 7672750 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Phase Advancement
Number of subjects: 27
Study 7672750 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnographic study
Number of subjects: 27
Study 2184330 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunization with killed Haemophilus influenzae
Number of subjects: 0
Study 2184330 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0
Study 7023086 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal and peridural injection of 0.5 ml (= 10 mg) Triamcinolone hexacetonide
Number of subjects: 35
Study 7023086 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 35
Study 31525420 — intervention group
Group type: COMPARATOR
Intervention: Pictorial fruit nudge (grape image) on plate
Number of subjects: 122
Study 31525420 — intervention group
Group type: COMPARATOR
Intervention: Large portion pictorial nudge (large portion carrot image)
Number of subjects: 122
Study 31525420 — intervention group
Group type: COMPARATOR
Intervention: Small portion pictorial nudge (small portion carrot image)
Number of subjects: 122
Study 31450986 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid-based prime solution
Number of subjects: 21
Study 31450986 — intervention group
Group type: COMPARATOR
Intervention: Erythrocyte-based prime solution (control)
Number of subjects: 21
Study 28079534 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan 20mg once daily for 16 weeks
Number of subjects: 84
Study 28079534 — intervention group
Group type: EXPERIMENTAL
Intervention: Azilsartan 20mg once daily for 16 weeks
Number of subjects: 84
Study 24197518 — intervention group
Group type: EXPERIMENTAL
Intervention: Red LED therapy (630 ± 10 nm)
Number of subjects: 30
Study 24197518 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared LED therapy (850 ± 10 nm)
Number of subjects: 30
Study 24197518 — intervention group
Group type: COMPARATOR
Intervention: Infrared laser therapy (780 nm) - Positive control group
Number of subjects: 30
Study 24192067 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-based learning (EBL)
Number of subjects: 135
Study 24192067 — intervention group
Group type: COMPARATOR
Intervention: Errorless learning (ELL)
Number of subjects: 135
Study 21334229 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-guided puncture technique (IGPT)
Number of subjects: 178
Study 21334229 — intervention group
Group type: COMPARATOR
Intervention: Conventional puncture technique (CPT)
Number of subjects: 178
Study 19605885 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid delivered by clinician during office visit
Number of subjects: 98
Study 19605885 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet about cholesterol
Number of subjects: 98
Study 16567610 — intervention group
Group type: EXPERIMENTAL
Intervention: BGMOM intervention (BGM+)
Number of subjects: 199
Study 16567610 — intervention group
Group type: COMPARATOR
Intervention: Attention control (BG meter only [MT])
Number of subjects: 199
Study 16567610 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 199
Study 12669392 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy for malignant gliomas
Number of subjects: 0
Study 12669392 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for low-grade gliomas
Number of subjects: 0
Study 12669392 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for medulloblastoma
Number of subjects: 0
Study 12669392 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy for germinoma and primary CNS lymphoma
Number of subjects: 0
Study 12669392 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT (Intensity-Modulated Radiation Therapy)
Number of subjects: 0
Study 11059542 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathing 2-5 minutes after birth
Number of subjects: 187
Study 11059542 — intervention group
Group type: COMPARATOR
Intervention: Dry care (control)
Number of subjects: 187
Study 9296277 — intervention group
Group type: EXPERIMENTAL
Intervention: Innogem 300 mg capsule
Number of subjects: 19
Study 9296277 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation
Number of subjects: 19
Study 8345499 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg verapamil
Number of subjects: 40
Study 8345499 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nitrendipine
Number of subjects: 40
Study 8345499 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (10 mg nitrendipine plus 120 mg verapamil)
Number of subjects: 40
Study 8345499 — intervention group
Group type: COMPARATOR
Intervention: Single drug therapy (240 mg verapamil or 20 mg nitrendipine)
Number of subjects: 40
Study 8345499 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 40
Study 3027839 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of itraconazole per day for seven days
Number of subjects: 28
Study 3027839 — intervention group
Group type: COMPARATOR
Intervention: 200 mg of itraconazole per day for five days
Number of subjects: 28
Study 29271795 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (physical exercise and psychoeducational consultations)
Number of subjects: 210
Study 29271795 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 210